emtricitabine has been researched along with Hepadnaviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jamard, C; Martin, P; Rimsky, L; Schorr, O; Seignères, B; Trépo, C; Werle, B; Zoulim, F | 1 |
| Aldrich, CE; Averett, DR; Cullen, JM; Fourel, I; Mason, WS; Pugh, J; Saputelli, J; Schaffer, P | 1 |
2 other study(ies) available for emtricitabine and Hepadnaviridae Infections
| Article | Year |
|---|---|
Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Blotting, Southern; Cell Survival; Deoxycytidine; Dioxolanes; Disease Models, Animal; Drug Therapy, Combination; Ducks; Emtricitabine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis B, Chronic; Hepatitis, Viral, Animal; Hepatocytes; Polymerase Chain Reaction; Purine Nucleosides; Reverse Transcriptase Inhibitors; Viral Load; Virus Replication | 2003 |
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
Topics: Animals; Antigens, Viral; Antiviral Agents; Biopsy; Bromodeoxyuridine; Deoxyguanosine; DNA Replication; DNA, Viral; Ducks; Emtricitabine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Kinetics; Liver; Time Factors; Virus Replication; Zalcitabine | 1994 |